Drug intelligence / Profile preview

Tricomin

Development stage
Unknown
Lead developer
PhotoMedex
Modality
Peptides
Administration
Topical
01

Overview

Tricomin is a topical cosmeceutical product line designed to treat hair loss and thinning hair in both men and women. Its primary active ingredient is the **Triamino Copper Complex** (AHK-Cu), a patented blend of copper and amino acids. The mechanism of action involves enhancing follicle health and scalp function; copper peptides are believed to stimulate follicle activity and potentially inhibit **5-alpha reductase**, the enzyme responsible for converting testosterone into dihydrotestosterone (DHT), a key factor in androgenetic alopecia. Originally developed by **Procyte Corporation** and currently marketed by **NEOVA SmartSkincare**, Tricomin has undergone Phase II clinical trials demonstrating efficacy in improving hair density and follicle health. It is typically formulated as a follicle spray, shampoo, or conditioner.

Brand names
TricominTricomin Clinical
Other names
Triamino Copper ComplexAHK-CuCopper tripeptide-3
02

Targets

SRD5A (Steroid 5-alpha-reductase)

Beyond the preview

Go deeper on Tricomin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tricomin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call